transdermal ozone keeps lipid oxidation markers near healthy baseline levels
Ozone treatment maintained malondialdehyde (MDA) concentrations at non-diabetic control levels in STZ-induced diabetic rats (0.068 ± 0.003 vs 0.133 ± 0.008 nmol/mg protein in untreated diabetic rats).
What this means for you
Malondialdehyde is a marker your body produces when fats in your cells get damaged by oxidative stress — and lower levels suggest your cells are holding up better under pressure. Keeping that marker near healthy-range levels points to stronger cellular resilience, which most people associate with slower aging, less inflammation, and better day-to-day recovery.
The published research
Ozone Therapy Effects in the Oxidative Stress Associated
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.